DVAX logo

Dynavax Technologies (DVAX) EBIT

annual EBIT:

$37.65M+$35.26M(+1475.27%)
December 31, 2024

Summary

  • As of today (May 21, 2025), DVAX annual earnings before interest & taxes is $37.65 million, with the most recent change of +$35.26 million (+1475.27%) on December 31, 2024.
  • During the last 3 years, DVAX annual EBIT has fallen by -$51.05 million (-57.55%).
  • DVAX annual EBIT is now -87.49% below its all-time high of $301.03 million, reached on December 31, 2022.

Performance

DVAX EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherDVAXincome statement metrics

quarterly EBIT:

-$96.47M-$106.67M(-1046.17%)
March 1, 2025

Summary

  • As of today (May 21, 2025), DVAX quarterly earnings before interest & taxes is -$96.47 million, with the most recent change of -$106.67 million (-1046.17%) on March 1, 2025.
  • Over the past year, DVAX quarterly EBIT has dropped by -$86.38 million (-856.29%).
  • DVAX quarterly EBIT is now -173.76% below its all-time high of $130.79 million, reached on June 30, 2022.

Performance

DVAX quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherDVAXincome statement metrics

TTM EBIT:

-$48.73M-$86.38M(-229.44%)
March 1, 2025

Summary

  • As of today (May 21, 2025), DVAX TTM earnings before interest & taxes is -$48.73 million, with the most recent change of -$86.38 million (-229.44%) on March 1, 2025.
  • Over the past year, DVAX TTM EBIT has dropped by -$63.34 million (-433.58%).
  • DVAX TTM EBIT is now -114.63% below its all-time high of $333.10 million, reached on September 30, 2022.

Performance

DVAX TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherDVAXincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

DVAX EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+1475.3%-856.3%-433.6%
3 y3 years-57.5%-379.3%-141.4%
5 y5 years+127.8%-1126.7%+54.3%

DVAX EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-87.5%+1475.3%-173.8%at low-114.6%at low
5 y5-year-87.5%+127.8%-173.8%at low-114.6%+57.7%
alltimeall time-87.5%+125.2%-173.8%at low-114.6%+67.5%

DVAX EBIT History

DateAnnualQuarterlyTTM
Mar 2025
-
-$96.47M(-1046.2%)
-$48.73M(-229.4%)
Dec 2024
$37.65M(+1475.3%)
$10.20M(-52.0%)
$37.65M(+21.5%)
Sep 2024
-
$21.23M(+30.1%)
$30.98M(+22.4%)
Jun 2024
-
$16.32M(-261.7%)
$25.31M(+73.2%)
Mar 2024
-
-$10.09M(-386.1%)
$14.61M(+511.3%)
Dec 2023
$2.39M(-99.2%)
$3.53M(-77.3%)
$2.39M(-96.6%)
Sep 2023
-
$15.55M(+177.0%)
$69.33M(-41.9%)
Jun 2023
-
$5.62M(-125.2%)
$119.28M(-51.2%)
Mar 2023
-
-$22.31M(-131.7%)
$244.45M(-18.9%)
Dec 2022
$301.03M(+239.4%)
$70.47M(+7.6%)
$301.30M(-9.5%)
Sep 2022
-
$65.50M(-49.9%)
$333.10M(+38.3%)
Jun 2022
-
$130.79M(+278.7%)
$240.84M(+104.7%)
Mar 2022
-
$34.54M(-66.2%)
$117.63M(+32.6%)
Dec 2021
$88.70M(-257.9%)
$102.27M(-482.2%)
$88.70M(-466.0%)
Sep 2021
-
-$26.75M(-452.9%)
-$24.23M(-306.8%)
Jun 2021
-
$7.58M(+35.3%)
$11.72M(-127.4%)
Mar 2021
-
$5.60M(-152.6%)
-$42.71M(-24.0%)
Dec 2020
-$56.18M(-58.6%)
-$10.66M(-216.0%)
-$56.18M(-27.4%)
Sep 2020
-
$9.20M(-119.6%)
-$77.41M(-32.9%)
Jun 2020
-
-$46.85M(+495.7%)
-$115.28M(+8.2%)
Mar 2020
-
-$7.86M(-75.3%)
-$106.55M(-21.4%)
Dec 2019
-$135.62M(-9.3%)
-$31.89M(+11.2%)
-$135.62M(-3.8%)
Sep 2019
-
-$28.68M(-24.8%)
-$140.95M(-6.1%)
Jun 2019
-
-$38.12M(+3.2%)
-$150.06M(+0.9%)
Mar 2019
-
-$36.94M(-0.8%)
-$148.70M(-0.6%)
Dec 2018
-$149.56M(+57.2%)
-$37.22M(-1.5%)
-$149.56M(+5.2%)
Sep 2018
-
-$37.79M(+2.8%)
-$142.12M(+12.2%)
Jun 2018
-
-$36.75M(-2.8%)
-$126.71M(+14.9%)
Mar 2018
-
-$37.80M(+27.0%)
-$110.28M(+15.9%)
Dec 2017
-$95.15M(-15.4%)
-$29.77M(+33.0%)
-$95.15M(+10.1%)
Sep 2017
-
-$22.39M(+10.2%)
-$86.44M(-12.6%)
Jun 2017
-
-$20.32M(-10.4%)
-$98.88M(-8.3%)
Mar 2017
-
-$22.67M(+7.7%)
-$107.82M(-4.1%)
Dec 2016
-$112.44M(+5.9%)
-$21.06M(-39.6%)
-$112.44M(-4.9%)
Sep 2016
-
-$34.84M(+19.1%)
-$118.25M(+4.2%)
Jun 2016
-
-$29.25M(+7.2%)
-$113.47M(+5.5%)
Mar 2016
-
-$27.29M(+1.6%)
-$107.55M(+1.2%)
Dec 2015
-$106.22M(+17.1%)
-$26.86M(-10.6%)
-$106.22M(+5.0%)
Sep 2015
-
-$30.06M(+28.9%)
-$101.15M(-0.0%)
Jun 2015
-
-$23.33M(-10.2%)
-$101.16M(-1.5%)
Mar 2015
-
-$25.97M(+19.2%)
-$102.69M(+13.2%)
Dec 2014
-$90.69M(+36.4%)
-$21.79M(-27.6%)
-$90.69M(+10.9%)
Sep 2014
-
-$30.08M(+21.0%)
-$81.81M(+21.4%)
Jun 2014
-
-$24.85M(+77.9%)
-$67.38M(+12.9%)
Mar 2014
-
-$13.97M(+8.2%)
-$59.66M(-10.3%)
Dec 2013
-$66.49M
-$12.91M(-17.5%)
-$66.49M(-9.6%)
DateAnnualQuarterlyTTM
Sep 2013
-
-$15.65M(-8.7%)
-$73.54M(-2.1%)
Jun 2013
-
-$17.14M(-17.6%)
-$75.09M(+3.6%)
Mar 2013
-
-$20.79M(+4.2%)
-$72.47M(+7.2%)
Dec 2012
-$67.60M(+44.9%)
-$19.96M(+16.0%)
-$67.60M(+31.4%)
Sep 2012
-
-$17.20M(+18.5%)
-$51.44M(+4.9%)
Jun 2012
-
-$14.52M(-8.8%)
-$49.06M(+9.8%)
Mar 2012
-
-$15.92M(+319.2%)
-$44.68M(-4.3%)
Dec 2011
-$46.64M(-16.2%)
-$3.80M(-74.4%)
-$46.69M(-29.9%)
Sep 2011
-
-$14.82M(+46.0%)
-$66.58M(+13.8%)
Jun 2011
-
-$10.15M(-43.4%)
-$58.51M(-9.5%)
Mar 2011
-
-$17.93M(-24.3%)
-$64.63M(+16.1%)
Dec 2010
-$55.65M(+268.2%)
-$23.68M(+250.8%)
-$55.65M(+27.7%)
Sep 2010
-
-$6.75M(-58.5%)
-$43.59M(-8.3%)
Jun 2010
-
-$16.27M(+81.8%)
-$47.55M(+67.4%)
Mar 2010
-
-$8.95M(-22.9%)
-$28.41M(+88.0%)
Dec 2009
-$15.12M(-37.3%)
-$11.61M(+8.4%)
-$15.12M(+839.4%)
Sep 2009
-
-$10.71M(-473.6%)
-$1.61M(-148.1%)
Jun 2009
-
$2.87M(-34.0%)
$3.35M(-154.3%)
Mar 2009
-
$4.34M(+129.5%)
-$6.16M(-74.5%)
Dec 2008
-$24.12M(-66.1%)
$1.89M(-132.9%)
-$24.12M(-39.7%)
Sep 2008
-
-$5.76M(-13.2%)
-$40.03M(-25.1%)
Jun 2008
-
-$6.63M(-51.3%)
-$53.45M(-22.1%)
Mar 2008
-
-$13.62M(-2.8%)
-$68.64M(-3.5%)
Dec 2007
-$71.09M(+16.9%)
-$14.02M(-26.9%)
-$71.09M(-10.1%)
Sep 2007
-
-$19.18M(-12.1%)
-$79.07M(+4.1%)
Jun 2007
-
-$21.82M(+35.7%)
-$75.99M(+11.8%)
Mar 2007
-
-$16.08M(-26.9%)
-$67.97M(+11.8%)
Dec 2006
-$60.80M(+170.4%)
-$21.99M(+36.6%)
-$60.80M(+25.9%)
Sep 2006
-
-$16.10M(+16.6%)
-$48.28M(+18.1%)
Jun 2006
-
-$13.81M(+55.0%)
-$40.90M(+13.3%)
Mar 2006
-
-$8.91M(-5.9%)
-$36.10M(+60.5%)
Dec 2005
-$22.49M(+33.4%)
-$9.47M(+8.7%)
-$22.49M(+21.5%)
Sep 2005
-
-$8.71M(-3.3%)
-$18.52M(+31.4%)
Jun 2005
-
-$9.01M(-291.6%)
-$14.09M(+72.4%)
Mar 2005
-
$4.70M(-185.6%)
-$8.17M(-51.5%)
Dec 2004
-$16.86M(-5.1%)
-$5.50M(+28.2%)
-$16.86M(-42.4%)
Sep 2004
-
-$4.29M(+38.4%)
-$29.25M(+17.3%)
Jun 2004
-
-$3.10M(-22.3%)
-$24.94M(+14.7%)
Mar 2004
-
-$3.98M(-77.7%)
-$21.75M(-3.3%)
Dec 2003
-$17.76M(-4.8%)
-$17.88M(<-9900.0%)
-$22.48M(+388.8%)
Sep 2003
-
$23.00K(-76.0%)
-$4.60M(-0.5%)
Jun 2003
-
$96.00K(-102.0%)
-$4.62M(-2.0%)
Mar 2003
-
-$4.72M
-$4.72M
Dec 2002
-$18.66M(-4.5%)
-
-
Dec 2001
-$19.53M(+66.7%)
-
-
Dec 2000
-$11.72M
-
-

FAQ

  • What is Dynavax Technologies annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Dynavax Technologies?
  • What is Dynavax Technologies annual EBIT year-on-year change?
  • What is Dynavax Technologies quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Dynavax Technologies?
  • What is Dynavax Technologies quarterly EBIT year-on-year change?
  • What is Dynavax Technologies TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Dynavax Technologies?
  • What is Dynavax Technologies TTM EBIT year-on-year change?

What is Dynavax Technologies annual earnings before interest & taxes?

The current annual EBIT of DVAX is $37.65M

What is the all time high annual EBIT for Dynavax Technologies?

Dynavax Technologies all-time high annual earnings before interest & taxes is $301.03M

What is Dynavax Technologies annual EBIT year-on-year change?

Over the past year, DVAX annual earnings before interest & taxes has changed by +$35.26M (+1475.27%)

What is Dynavax Technologies quarterly earnings before interest & taxes?

The current quarterly EBIT of DVAX is -$96.47M

What is the all time high quarterly EBIT for Dynavax Technologies?

Dynavax Technologies all-time high quarterly earnings before interest & taxes is $130.79M

What is Dynavax Technologies quarterly EBIT year-on-year change?

Over the past year, DVAX quarterly earnings before interest & taxes has changed by -$86.38M (-856.29%)

What is Dynavax Technologies TTM earnings before interest & taxes?

The current TTM EBIT of DVAX is -$48.73M

What is the all time high TTM EBIT for Dynavax Technologies?

Dynavax Technologies all-time high TTM earnings before interest & taxes is $333.10M

What is Dynavax Technologies TTM EBIT year-on-year change?

Over the past year, DVAX TTM earnings before interest & taxes has changed by -$63.34M (-433.58%)
On this page